MENU

Panjiva_research_logo

Roche, Biomerieux rescue falling U.S. test kit imports in May after weak April

Coronavirus 303 Health Care 203 U.S. 4297

The U.S. FDA has told Congress that there were few restrictions on pharmaceutical imports during the COVID-19 crisis. Looking more broadly at medical supplies there has been a marked improvement in imports to the U.S. using trade authority definitions in April versus March. Imports of medical supplies in total rose by 11.7% sequentially in April including a 122% surge in protective equipment, a 5.9% increase in pharmaceuticals and 5.3% improvement in ventilators. Imports of test kits however fell by 25.8%. Imports of personal protective equipment including masks, shields and gloves speci...

Copyright © 2020 Panjiva Supply Chain Intelligence, a product offering from S&P Global Market Intelligence Inc. All rights reserved.